BDPWM
GILD icon

Barnes Dennig Private Wealth Management’s Gilead Sciences GILD Stock Holding History

Barnes Dennig Private Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-139
Closed -$15.6K – 306
2025
Q1 		$15.6K Buy
+139
New +$14.3K 0.02% 113

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Barnes Dennig Private Wealth Management's GILD Position: Q2 2025 in Review

Barnes Dennig Private Wealth Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 139 shares — an estimated $15.6K sold.

Barnes Dennig Private Wealth Management first reported a position in GILD in Q1 2025 and held it in 1 quarter. The position peaked at $15.6K in Q1 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Barnes Dennig Private Wealth Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Barnes Dennig Private Wealth Management sold 139 Gilead Sciences shares in Q2 2025, an estimated $15.6K.
  • Barnes Dennig Private Wealth Management first reported a position in Gilead Sciences in Q1 2025 and held it in 1 quarter.
  • Barnes Dennig Private Wealth Management's Gilead Sciences position peaked at $15.6K in Q1 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Barnes Dennig Private Wealth Management's 13F filing for Q2 2025, filed 4 Aug 2025.